ArticleExperimental cell research2020

Protein kinase C inhibitor anchored BRD4 PROTAC PEGylated nanoliposomes for the treatment of vemurafenib-resistant melanoma.

Yige Fu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.